MedPath

Online Group Psychological Intervention for People With Emotional Disorders

Not Applicable
Conditions
To Assess the Clinical Usefulness and Acceptability Level of the UP Online Group Format in Argentina as Well as Participants' Satisfaction
Interventions
Behavioral: Unified Protocol
Registration Number
NCT05275322
Lead Sponsor
University of Buenos Aires
Brief Summary

Participants will receive an online synchronous group therapy based on the Unified Protocol (UP) model for 11 subsequent weeks, with 90-minute meetings. After every session, they will be sent the chapter with the notions addressed in the session from the UP's patient manual (Barlow et al., 2011) and the scales to work with during the week.

Participants in the waiting list will complete the evaluation scales at the same time as people in the intervention group (before the intervention, in the middle, after the intervention, three months after and six months after). After this period they will receive the group therapy based on the UP.

The group admission criteria are: 1) being 18 years old or older; 2) submitting the informed consent; 3) agreeing to participate in all the scheduled sessions; 4) agreeing to have the sessions recorded (both audio and video) for oversight purposes; 5) submitting a primary diagnosis of an anxiety disorder (e.g., panic disorder; agoraphobia; social anxiety disorder; generalized anxiety disorder; unspecific anxiety disorder), unipolar depression (major depressive disorder; dysthymia), obsessive-compulsive disorder, or post-traumatic stress disorder, according to DSM criteria and disrupting individuals' daily life or causing significant discomfort.

The group exclusion criteria are: 1) comorbidity with psychotic disorders, bipolar disorder, eating disorders, borderline personality disorder, or active severe suicidal ideation, and 2) currently receiving pharmacological treatment. All candidates who are not included in the group will be informed of this decision and will be given information on places to seek treatment. Evaluations will be carried out via video calls on the Google Meet platform, using the MINI (Ferrando et al., 2000) and SCID-II (Grilo, Anez \& McGlashan, 2003) diagnostic interviews.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
    1. being 18 years old or older; 2) submitting the informed consent; 3) agreeing to participate in all the scheduled sessions; 4) agreeing to have the sessions recorded (both audio and video) for oversight purposes; 5) submitting a primary diagnosis of an anxiety disorder (e.g., panic disorder; agoraphobia; social anxiety disorder; generalized anxiety disorder; unspecific anxiety disorder), unipolar depression (major depressive disorder; dysthymia), obsessive-compulsive disorder, or post-traumatic stress disorder, according to DSM criteria and disrupting individuals' daily life or causing significant discomfort.
Exclusion Criteria
    1. comorbidity with psychotic disorders, bipolar disorder, eating disorders, borderline personality disorder, or active severe suicidal ideation, and 2) currently receiving pharmacological treatment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Treatment groupUnified Protocol-
Primary Outcome Measures
NameTimeMethod
Beck Depression Inventory II5 weeks

Beck Depression Inventory II (BDI II; Beck et al, 2006; Argentine adaptation by Brenlla \& RodrĂ­guez, 2006). The BDI II is a questionnaire designed to gauge how severe people's depressive symptoms are. It includes 21 items that probe the typical symptoms of a depressive episode. Every item features 4 options, ranging from 0 (not at all) to 3 (severe, nearly unbearable), on a Likert-type scale. It was validated and adapted to Argentina's population, with an adequate internal consistency and a Cronbach alpha coefficient of .88.

Beck Anxiety Inventory5 weeks

Beck Anxiety Inventory (BAI; Beck et al., 1988; Argentine adaptation by Vizioli \& Pagano, 2020). The BAI is an inventory designed to measure the severity of anxiety symptoms. It consists of 21 items, each addressing an anxiety symptom. Every item is rated on a Likert scale answer format that goes from 0 (not at all) to 4 (it upset me very much). This instrument was validated and adapted to Argentina's setting, with a Cronbach alpha coefficient of 0.93.

Secondary Outcome Measures
NameTimeMethod
Positive and Negative Affect Schedule5 weeks

Positive and Negative Affect Schedule (PANAS; Thompson, 2007; Argentine adaptation by Moriondo et al., 2012). The PANAS inventory has been designed to measure affect in a dimensional fashion (negative affect and positive affect). The short version designed by Thompson (2007) and adapted to Argentina by Moriondo et al. (2012) has been chosen. This version covers four dimensions: trait positive affect (five items), trait negative affect (five items), state positive affect (five items), and state negative affect (five items). Every item uses a Likert-type scale rating from 1 (slightly or not at all) through 5 (very much or totally). This instrument features a Cronbach alpha coefficient of .73 (Cronbach alpha coefficient of .84 for Negative Affect and .75 for Positive Affect).

Difficulties in Emotion Regulation Scale5 weeks

Difficulties in Emotion Regulation Scale (DERS; Gratz \& Roemer, 2004; Argentine adaptation by Cremades et al., 2021). This scale measures the extent to which people use several Emotional Regulation strategies. The adapted scale includes 30 self-administered items with a Likert-type five-option scale that goes from 1 (hardly ever) to 5 (almost always) and a six-factor structure, including: (1) impulse control difficulties (six items); (2) limited access to emotional regulation strategies (six items); (3) lacking emotional acceptance (six items); (4) interference in goal-oriented behaviors (four items); (5) lacking emotional awareness (three items), and (6) lacking emotional clarity (six items).

Trial Locations

Locations (1)

Faculty of Psychology, University of Buenos Aires

🇦🇷

Buenos Aires, Ciudad AutĂłnoma De Buenos Aires, Argentina

© Copyright 2025. All Rights Reserved by MedPath